NO175059C - - Google Patents

Info

Publication number
NO175059C
NO175059C NO872716A NO872716A NO175059C NO 175059 C NO175059 C NO 175059C NO 872716 A NO872716 A NO 872716A NO 872716 A NO872716 A NO 872716A NO 175059 C NO175059 C NO 175059C
Authority
NO
Norway
Application number
NO872716A
Other languages
Norwegian (no)
Other versions
NO872716L (no
NO872716D0 (no
NO175059B (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO872716D0 publication Critical patent/NO872716D0/no
Publication of NO872716L publication Critical patent/NO872716L/no
Publication of NO175059B publication Critical patent/NO175059B/no
Publication of NO175059C publication Critical patent/NO175059C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO872716A 1986-06-30 1987-06-29 Fremgangsmåte for fremstilling av i det vesentlige rene, partielle eller totale estere av alginsyre NO175059B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48201/86A IT1203814B (it) 1986-06-30 1986-06-30 Esteri dell'acido alginico

Publications (4)

Publication Number Publication Date
NO872716D0 NO872716D0 (no) 1987-06-29
NO872716L NO872716L (no) 1988-01-04
NO175059B NO175059B (no) 1994-05-16
NO175059C true NO175059C (en:Method) 1994-08-24

Family

ID=11265177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872716A NO175059B (no) 1986-06-30 1987-06-29 Fremgangsmåte for fremstilling av i det vesentlige rene, partielle eller totale estere av alginsyre

Country Status (24)

Country Link
US (1) US5336668A (en:Method)
EP (2) EP0609968A3 (en:Method)
JP (2) JP2569054B2 (en:Method)
CN (1) CN1026001C (en:Method)
AR (1) AR242959A1 (en:Method)
AT (1) ATE113610T1 (en:Method)
AU (2) AU602901B2 (en:Method)
CA (1) CA1338235C (en:Method)
DE (1) DE3750710T2 (en:Method)
DK (1) DK333687A (en:Method)
EG (1) EG18197A (en:Method)
FI (1) FI872878A7 (en:Method)
HU (1) HU202559B (en:Method)
IL (1) IL82943A (en:Method)
IN (1) IN166549B (en:Method)
IT (1) IT1203814B (en:Method)
MX (1) MX7108A (en:Method)
NO (1) NO175059B (en:Method)
NZ (1) NZ220807A (en:Method)
PH (1) PH25729A (en:Method)
PL (1) PL157922B1 (en:Method)
PT (1) PT85200B (en:Method)
YU (2) YU46960B (en:Method)
ZA (1) ZA874520B (en:Method)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
JP2627344B2 (ja) * 1990-01-23 1997-07-02 工業技術院長 水溶性アルギン繊維及びその製造方法
US5332809A (en) * 1991-02-11 1994-07-26 Fidia S.P.A. Partial esters of gellan
IT1247472B (it) 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
IT1263755B (it) * 1991-09-16 1996-08-29 Fidia Spa Uso di esteri della colina con polisaccaridi acidi come agenti antiulcera e gastroprotettivi
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
IT1254170B (it) * 1991-12-18 1995-09-11 Mini Ricerca Scient Tecnolog Membrane composite per la rigenerazione guidata di tessuti
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
US5824335A (en) * 1991-12-18 1998-10-20 Dorigatti; Franco Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
FR2699545B1 (fr) * 1992-12-18 1995-01-27 Oreal Agent gélifiant résultant de l'association d'un chitosane et d'un alginate d'alkyle ou d'hydroxyalkyle et son utilisation dans la préparation de compositions cosmétiques et pharmaceutiques.
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
IT1268955B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Esteri attivi di polisaccaridi carbossilici
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
CN1141149C (zh) * 1995-02-07 2004-03-10 菲迪亚高级生物多聚合物有限公司 用透明质酸、其衍生物或其它天然或半合成聚合物涂覆物体表面的方法
IT1281886B1 (it) * 1995-05-22 1998-03-03 Fidia Advanced Biopolymers Srl Processo per la preparazione di idrogel ottenuti da derivati chimici dell'acido ialuronico mediante irradiazioni ultraviolette e loro
FR2764505B1 (fr) * 1997-06-13 1999-10-15 Alain Dogliani Nouvelles compositions cosmetiques a base de lyophilisats d'alginates alcalins et nouveaux vecteurs de penetration
IT1294797B1 (it) 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
FR2778081B1 (fr) * 1998-04-29 2000-08-25 Fabrice Thevenet Implants de renfort pour sutures tissulaires
FR2781677B1 (fr) * 1998-07-31 2000-10-20 Brothier Lab Dispositif de traitement de plaies et procede de fabrication de ce dispositif
EP1374908A3 (en) 1998-10-09 2004-03-24 The Regents Of The University Of Michigan Polymer-drug conjugates comprising hydrazide linkers
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
JP3814224B2 (ja) * 2001-04-25 2006-08-23 エーザイ株式会社 外用組成物
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
KR101174510B1 (ko) 2002-09-11 2012-08-16 프레제니우스 카비 도이치란트 게엠베하 하이드록시알킬전분화 폴리펩티드, 특히 하이드록시알킬전분화 에리트로포이에틴
US7538092B2 (en) 2002-10-08 2009-05-26 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
FR2850281A1 (fr) * 2003-01-27 2004-07-30 Brothier Lab Procede de fabrication d'un dispositif de renfort de suture
US7008476B2 (en) * 2003-06-11 2006-03-07 Az Electronic Materials Usa Corp. Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
GB2404920A (en) * 2003-08-12 2005-02-16 Johnson & Johnson Medical Ltd Antimicrobial polymer
WO2005030257A2 (en) * 2003-09-30 2005-04-07 Solubest Ltd. Water soluble nanoparticles inclusion complexes
BRPI0508607A (pt) 2004-03-11 2007-07-31 Fresenius Kabi De Gmbh conjugados de amido de hidroxialquila e uma proteìna, preparados pela aminação redutiva
PE20060468A1 (es) * 2004-04-26 2006-07-06 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad de la piel que comprende polisacaridos de acido carboxilico
DE102004025495A1 (de) 2004-05-21 2005-12-15 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
GB0513552D0 (en) 2005-07-01 2005-08-10 Bristol Myers Squibb Co Bandage
DE102005049833A1 (de) * 2005-10-14 2007-04-19 Beiersdorf Ag Hydrophob modifizierte Alginate
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
FR2936800B1 (fr) * 2008-10-06 2010-12-31 Adocia Polysaccharide comportant des groupes fonctionnels carboxyles substitues par un derive d'alcool hydrophobe
US8426382B2 (en) 2008-10-06 2013-04-23 Adocia Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
JP2010106068A (ja) * 2008-10-28 2010-05-13 Mie Prefecture 多糖類の新規化学修飾法
WO2010069519A1 (en) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
WO2012085609A1 (en) 2010-12-20 2012-06-28 Dept. Of Pathobiology Treatment of osteoarthritis by continuous intra-articular injection of alginate gel
US9422373B2 (en) * 2011-06-02 2016-08-23 Massachusetts Institute Of Technology Modified alginates for cell encapsulation and cell therapy
DE102012208321A1 (de) 2012-05-18 2013-11-21 Robert Bosch Gmbh Alginate als Binder für Batterie-Kathoden
JP6570548B2 (ja) 2014-05-19 2019-09-04 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 多孔質アルギネート系エアロゲルの生成方法
AU2015295986B2 (en) * 2014-08-01 2018-11-08 Massachusetts Institute Of Technology Modified alginates for anti-fibrotic materials and applications
ES2978718T3 (es) 2015-11-01 2024-09-18 Massachusetts Inst Technology Alginatos modificados para materiales antifibróticos y aplicaciones
WO2017075630A1 (en) 2015-11-01 2017-05-04 Massachusetts Institute Of Technology Materials with improved properties
KR20190020318A (ko) 2016-06-13 2019-02-28 메사추세츠 인스티튜트 오브 테크놀로지 이물질 반응 및 섬유화를 감소시키기 위한 생체적합성 코팅 및 하이드로겔
WO2019090309A1 (en) 2017-11-06 2019-05-09 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
KR20250022896A (ko) * 2018-01-16 2025-02-17 가부시키가이샤 도쿠야마 차아염소산 이온을 포함하는 반도체 웨이퍼의 처리액
WO2019197184A1 (en) 2018-04-09 2019-10-17 Basf Polyurethanes Gmbh Aerogels and their use in cosmetic applications
CN109646705B (zh) * 2019-01-30 2022-06-14 深圳齐康医疗器械有限公司 复合海绵及其制备方法和负压引流敷料、装置与医疗设备
CN110946712B (zh) * 2019-12-31 2021-06-18 露乐健康科技股份有限公司 具有柔臀健脂护理功能的纸尿裤
WO2021174330A1 (en) * 2020-03-05 2021-09-10 Nuecology Biomedical Inc. Amphiphilic alginate-oleic acid macromolecules and process for preparation therof
CN111518226A (zh) * 2020-03-06 2020-08-11 沈阳科技学院 一种用于活性染料直接印花的印花糊料的制备方法
CN113208953A (zh) * 2021-04-16 2021-08-06 青岛海之林生物科技开发有限公司 一种海藻染发膏及其制备工艺
CN115850533B (zh) * 2022-09-28 2023-07-21 青岛格诚经纬生物科技有限公司 一种海藻酸材料及其制备方法、应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA499026A (en) * 1954-01-05 B. Steiner Arnold Alkylene glycol esters of alginic acid
US2158487A (en) * 1935-10-22 1939-05-16 Kelco Co Triethanolamine alginate product and process
US2426125A (en) * 1944-04-03 1947-08-19 Kelco Co Manufacture of glycol alginates
US2477861A (en) * 1945-11-28 1949-08-02 Donald E Clark Production of fibrous watersoluble alginates
US2494912A (en) * 1947-01-20 1950-01-17 Kelco Co Higher alkylene glycol esters of alginic acid
US2478988A (en) * 1947-03-05 1949-08-16 Walierstein Company Inc Process for improving the foam of fermented malt beverages and product obtained thereby
US2463824A (en) * 1947-08-02 1949-03-08 Kelco Co Substituted alkylene glycol esters of alginic acid
US2647035A (en) * 1951-06-30 1953-07-28 Celanese Corp Dyeing of textile materials using alkylamine alginate thickeners
US2694058A (en) * 1951-10-20 1954-11-09 Hoffmann La Roche Production of polyuronic acid derivatives
US3108042A (en) * 1952-04-07 1963-10-22 Lilly Co Eli Corticotropin reaction complexes
GB768309A (en) * 1954-03-27 1957-02-13 Henkel & Cie Gmbh Process for the production of amides of alginic acid
US2860130A (en) * 1954-11-01 1958-11-11 Kelco Co Methyl alginate
GB833946A (en) * 1957-03-08 1960-05-04 Nordson Pharmaceutical Lab Inc L-amphetamine alginate
US3115488A (en) * 1960-02-29 1963-12-24 American Home Prod Alginic acid methyl ester sulfates, preparation and molecular weight fractionation thereof
US3115458A (en) * 1960-05-11 1963-12-24 Michael J Bebech Apparatus for filtering liquids
GB976301A (en) * 1960-10-27 1964-11-25 Calmic Ltd Preparation and use of alginates
BE612782A (en:Method) * 1961-01-18
US3787389A (en) * 1961-04-24 1974-01-22 Purdue Frederick Co Pyrazolidone derivatives
US3790558A (en) * 1961-04-24 1974-02-05 Purdue Frederick Co Pyrazolidone derivatives substituted on the 4 position with pectin or algin
US3332933A (en) * 1964-02-21 1967-07-25 Kelco Co Diacyl n-alkyl ammonium alginates and their preparation
US3325472A (en) * 1964-06-18 1967-06-13 Mortimer D Sackler Polycyclohexose-polyoxyethyleneglycol suppository bases
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
US3351581A (en) * 1966-06-24 1967-11-07 Kelco Co Acetyl alginates and pectates and process of making the same
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
GB1174854A (en) * 1967-07-07 1969-12-17 Miles Lab New Biologically Active Conjugates
US3535308A (en) * 1968-01-15 1970-10-20 American Cyanamid Co Process for the preparation of partially esterified polyhydroxylic polymers
US3574641A (en) * 1968-03-29 1971-04-13 Kelco Co High neutralized propylene glycol alginate in french dressing
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3993073A (en) * 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
DK125598B (da) * 1969-09-29 1973-03-12 Grindstedvaerket As Fremgangsmåde til fremstilling af propylenglykolalginat.
US3792164A (en) * 1970-03-31 1974-02-12 Chemway Corp Ophthalmic composition comprising water-soluble alkaloid salts of polyuronic acids
DE2148279A1 (de) * 1970-09-30 1972-04-06 Unilever N V , Rotterdam (Nieder lande) Geruststoffe fur Detergensmittel
US3887175A (en) * 1970-11-19 1975-06-03 G A Cochard Lab Quinidine alginate and process of preparation thereof
CA942744A (en) * 1970-12-11 1974-02-26 David J. Pettitt Method for preparing propylene glycol esters of alginic acid
GB1375572A (en:Method) * 1971-08-12 1974-11-27
GB1395898A (en) * 1971-09-28 1975-05-29 Berenguer Beneyto Lab Dihydroquinidine derivative
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
US4206301A (en) * 1972-09-28 1980-06-03 Seymour Yolles Sustained flavor release composition
US3772266A (en) * 1972-10-19 1973-11-13 Kelco Co Process for the preparation of propylene glycol alginate from partially neutralized alginic acid
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
FR2247204A1 (en) * 1973-10-16 1975-05-09 Girardiere Gf Veterinary aerosol foams - contg alginic acid derivs as film-formers for injection into cows teats, vagina or uterus
US3946110A (en) * 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4002731A (en) * 1974-06-17 1977-01-11 Sterling Drug Inc. Diagnostic process using sodium tyropanoate
CA1019326A (en) * 1974-07-16 1977-10-18 Uniroyal Ltd. Process for the production of alkylene glycol alginates
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
CA1057746A (en) * 1975-09-16 1979-07-03 Merck And Co. Propylene glycol alginic acid esters
US4104460A (en) * 1976-09-14 1978-08-01 Nobuyasu Hasebe Method for treating seaweed with hydrogen peroxide or hydrogen peroxide compound
AT358147B (de) * 1976-12-03 1980-08-25 Gergely Gerhard Reinigungsmaterial
FR2418821A1 (fr) * 1978-03-03 1979-09-28 Adeline Andre Procede de fabrication de fibres d'alginate de calcium
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4364929A (en) * 1979-04-02 1982-12-21 The Purdue Frederick Company Germicidal colloidal lubricating gels and method of producing the same
JPS5953951B2 (ja) * 1979-04-02 1984-12-27 住友化学工業株式会社 繊維材料の浸染法
SE442705B (sv) * 1979-05-08 1986-01-27 Viktor Kare Larsson Medel for bildande av ett skyddsskikt pa ett underlag i form av hud eller slemhinna samt forfarande for att bilda ett skyddsskikt pa huden i icke-terapeutiskt syfte med hjelp av detta medel
FR2482603A1 (fr) * 1980-05-14 1981-11-20 Pharmindustrie Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
JPS58206751A (ja) * 1982-05-26 1983-12-02 日石三菱株式会社 創傷被覆材
US4512987A (en) * 1982-07-15 1985-04-23 Ciba-Geigy Corporation New pharmaceutical preparations
US4500676A (en) * 1983-12-15 1985-02-19 Biomatrix, Inc. Hyaluronate modified polymeric articles
JPS60226832A (ja) * 1984-04-02 1985-11-12 Daicel Chem Ind Ltd 多糖の脂肪族エステルを含む分離剤
JPH0680081B2 (ja) * 1984-04-11 1994-10-12 ダイセル化学工業株式会社 多糖類誘導体
JPH0699482B2 (ja) * 1984-04-16 1994-12-07 ダイセル化学工業株式会社 多糖類誘導体
JPS6130516A (ja) * 1984-07-20 1986-02-12 Nichiban Co Ltd 粘膜付着製剤
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
US4808707A (en) * 1987-06-08 1989-02-28 University Of Delaware Chitosan alginate capsules

Also Published As

Publication number Publication date
ATE113610T1 (de) 1994-11-15
CA1338235C (en) 1996-04-09
PL157922B1 (en) 1992-07-31
EP0609968A2 (en) 1994-08-10
FI872878L (fi) 1987-12-31
NO872716L (no) 1988-01-04
MX7108A (es) 1994-01-31
IL82943A (en) 1994-02-27
PH25729A (en) 1991-10-18
NZ220807A (en) 1992-03-26
JP2569054B2 (ja) 1997-01-08
EP0609968A3 (en) 1994-12-21
IT1203814B (it) 1989-02-23
CN87104499A (zh) 1988-04-06
AR242959A1 (es) 1993-06-30
AU651804B2 (en) 1994-08-04
YU84688A (en) 1989-10-31
NO872716D0 (no) 1987-06-29
FI872878A7 (fi) 1987-12-31
EP0251905B1 (en) 1994-11-02
EG18197A (en) 1992-09-30
AU7008491A (en) 1991-05-16
YU46960B (sh) 1994-09-09
JPH08311104A (ja) 1996-11-26
EP0251905A3 (en) 1988-07-20
YU46980B (sh) 1994-09-09
EP0251905A2 (en) 1988-01-07
IN166549B (en:Method) 1990-06-02
DK333687D0 (da) 1987-06-29
FI872878A0 (fi) 1987-06-30
PT85200A (en) 1987-07-01
IL82943A0 (en) 1987-12-20
JPS6333401A (ja) 1988-02-13
DK333687A (da) 1987-12-31
CN1026001C (zh) 1994-09-28
PT85200B (pt) 1990-03-30
IT8648201A0 (it) 1986-06-30
PL266544A1 (en) 1988-09-15
HU202559B (en) 1991-03-28
DE3750710D1 (de) 1994-12-08
ZA874520B (en) 1987-12-29
AU602901B2 (en) 1990-11-01
US5336668A (en) 1994-08-09
DE3750710T2 (de) 1995-03-16
AU7490987A (en) 1988-01-07
HUT43870A (en) 1987-12-28
NO175059B (no) 1994-05-16

Similar Documents

Publication Publication Date Title
IN166549B (en:Method)
GR3006559T3 (en:Method)
IN169437B (en:Method)
AU7131891A (en:Method)
IN169484B (en:Method)
IN165533B (en:Method)
IN169908B (en:Method)
US4677481B1 (en:Method)
DE3790744T1 (en:Method)
IN172017B (en:Method)
IN167941B (en:Method)
FR2611374B1 (en:Method)
FR2669626B1 (en:Method)
DE3690818T1 (en:Method)
IN167867B (en:Method)
IN166712B (en:Method)
IN168090B (en:Method)
GB2190018B (en:Method)
AU5745586A (en:Method)
AU6053586A (en:Method)
AU5753186A (en:Method)
AU5783386A (en:Method)
AU5857886A (en:Method)
AU5878886A (en:Method)
AU5724586A (en:Method)